Biomolecules (Jun 2022)
Keeping Cell Death Alive: An Introduction into the French Cell Death Research Network
- Gabriel Ichim,
- Benjamin Gibert,
- Sahil Adriouch,
- Catherine Brenner,
- Nathalie Davoust,
- Solange Desagher,
- David Devos,
- Svetlana Dokudovskaya,
- Laurence Dubrez,
- Jérôme Estaquier,
- Germain Gillet,
- Isabelle Guénal,
- Philippe P. Juin,
- Guido Kroemer,
- Patrick Legembre,
- Romain Levayer,
- Stéphen Manon,
- Patrick Mehlen,
- Olivier Meurette,
- Olivier Micheau,
- Bernard Mignotte,
- Florence Nguyen-Khac,
- Nikolay Popgeorgiev,
- Jean-Luc Poyet,
- Muriel Priault,
- Jean-Ehrland Ricci,
- Franck B. Riquet,
- Santos A. Susin,
- Magali Suzanne,
- Pierre Vacher,
- Ludivine Walter,
- Bertrand Mollereau
Affiliations
- Gabriel Ichim
- Cancer Cell Death Laboratory, Part of LabEx DEVweCAN, Cancer Initiation and Tumoral Cell Identity Department, CRCL, 69008 Lyon, France
- Benjamin Gibert
- Apoptosis, Cancer and Development Laboratory—Equipe Labellisée ‘La Ligue’, LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Claude Bernard University Lyon 1, 69008 Lyon, France
- Sahil Adriouch
- INSERM U1234, Pathophysiology, Autoimmunity, and ImmunoTHERapies (PANTHER), Normandie University, UNIROUEN, 76000 Rouen, France
- Catherine Brenner
- CNRS, Institut Gustave Roussy, Aspects Métaboliques et Systémiques de L’oncogénèse pour de Nouvelles Approches Thérapeutiques, Université Paris-Saclay, 94805 Villejuif, France
- Nathalie Davoust
- Laboratory of Biology and Modelling of the Cell, Ecole Normale Superieure of Lyon, CNRS, UMR 5239, INSERM U1293, University Claude Bernard Lyon 1, 46 allee d’Italie, F-69364 Lyon, France
- Solange Desagher
- Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, CNRS, 34293 Montpellier, France
- David Devos
- INSERM UMR-S-U1172, Lille Neurosciences & Cognition, University of Lille, CHU Lille, F-59000 Lille, France
- Svetlana Dokudovskaya
- CNRS, Institut Gustave Roussy, Aspects Métaboliques et Systémiques de L’oncogénèse pour de Nouvelles Approches Thérapeutiques, Université Paris-Saclay, 94805 Villejuif, France
- Laurence Dubrez
- Institut National de la Santé et de la Recherche Médicale (INSERM) INSERM LNC UMR1231, LabEx LipSTIC, 21000 Dijon, France
- Jérôme Estaquier
- INSERM U1124, Université Paris Cité, F-75006 Paris, France
- Germain Gillet
- Centre de Recherche en Cancérologie de Lyon, U1052 INSERM, UMR CNRS 5286, Centre Léon Bérard, Université Lyon I, 28 Rue Laennec, 69008 Lyon, France
- Isabelle Guénal
- LGBC, UVSQ, Université Paris-Saclay, 78000 Versailles, France
- Philippe P. Juin
- INSERM CRCI2 NA, Université de Nantes, F-44000 Nantes, France
- Guido Kroemer
- Institut Universitaire de France, Centre de Recherche des Cordeliers, Equipe Labellisée par la Ligue Contre le Cancer, Université de Paris, Sorbonne Université, INSERM U1138, 75006 Paris, France
- Patrick Legembre
- Contrôle de la Réponse Immune B et Lymphoproliférations, CRIBL, Université Limoges, UMR CNRS 7276, INSERM 1262, 87025 Limoges, France
- Romain Levayer
- Department of Developmental and Stem Cell Biology, Institut Pasteur, Université de Paris Cité, CNRS UMR3738, F-75015 Paris, France
- Stéphen Manon
- UMR 5095, CNRS, Université de Bordeaux, 33000 Bordeaux, France
- Patrick Mehlen
- Apoptosis, Cancer and Development Laboratory—Equipe Labellisée ‘La Ligue’, LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Claude Bernard University Lyon 1, 69008 Lyon, France
- Olivier Meurette
- Apoptosis, Cancer and Development Laboratory—Equipe Labellisée ‘La Ligue’, LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Claude Bernard University Lyon 1, 69008 Lyon, France
- Olivier Micheau
- INSERM, Lipides Nutrition Cancer, UMR 1231, Université de Bourgogne Franche-Comté, 21000 Dijon, France
- Bernard Mignotte
- LGBC, UVSQ, Université Paris-Saclay, 78000 Versailles, France
- Florence Nguyen-Khac
- Cell Death and Drug Resistance in Hematological Disorders Team, Centre de Recherche des Cordeliers, UMRS 1138, INSERM, Sorbonne Université, F-75006 Paris, France
- Nikolay Popgeorgiev
- Centre de Recherche en Cancérologie de Lyon, U1052 INSERM, UMR CNRS 5286, Centre Léon Bérard, Université Lyon I, 28 Rue Laennec, 69008 Lyon, France
- Jean-Luc Poyet
- INSERM, HIPI, Université Paris Cité, F-75475 Paris, France
- Muriel Priault
- CNRS, IBGC, UMR 5095, University Bordeaux, F-33000 Bordeaux, France
- Jean-Ehrland Ricci
- INSERM C3M, Equipe Labellisée LIGUE Contre le Cancer, Université Côte d’Azur, 06200 Nice, France
- Franck B. Riquet
- Cell Death and Inflammation Unit, VIB-UGent Center for Inflammation Research (IRC) & Department of Biomedical Molecular Biology (DBMB), Ghent University, B-9052 Ghent, Belgium
- Santos A. Susin
- Cell Death and Drug Resistance in Hematological Disorders Team, Centre de Recherche des Cordeliers, UMRS 1138, INSERM, Sorbonne Université, F-75006 Paris, France
- Magali Suzanne
- Centre de Biologie Intégrative, CNRS/UMR 5088, Université Toulouse III, 31062 Toulouse, France
- Pierre Vacher
- INSERM U1218, Institut Bergonié, 33000 Bordeaux, France
- Ludivine Walter
- Laboratory of Biology and Modelling of the Cell, Ecole Normale Superieure of Lyon, CNRS, UMR 5239, INSERM U1293, University Claude Bernard Lyon 1, 46 allee d’Italie, F-69364 Lyon, France
- Bertrand Mollereau
- Laboratory of Biology and Modelling of the Cell, Ecole Normale Superieure of Lyon, CNRS, UMR 5239, INSERM U1293, University Claude Bernard Lyon 1, 46 allee d’Italie, F-69364 Lyon, France
- DOI
- https://doi.org/10.3390/biom12070901
- Journal volume & issue
-
Vol. 12,
no. 7
p. 901
Abstract
Since the Nobel Prize award more than twenty years ago for discovering the core apoptotic pathway in C. elegans, apoptosis and various other forms of regulated cell death have been thoroughly characterized by researchers around the world. Although many aspects of regulated cell death still remain to be elucidated in specific cell subtypes and disease conditions, many predicted that research into cell death was inexorably reaching a plateau. However, this was not the case since the last decade saw a multitude of cell death modalities being described, while harnessing their therapeutic potential reached clinical use in certain cases. In line with keeping research into cell death alive, francophone researchers from several institutions in France and Belgium established the French Cell Death Research Network (FCDRN). The research conducted by FCDRN is at the leading edge of emerging topics such as non-apoptotic functions of apoptotic effectors, paracrine effects of cell death, novel canonical and non-canonical mechanisms to induce apoptosis in cell death-resistant cancer cells or regulated forms of necrosis and the associated immunogenic response. Collectively, these various lines of research all emerged from the study of apoptosis and in the next few years will increase the mechanistic knowledge into regulated cell death and how to harness it for therapy.
Keywords